The 2022 revision of the PIC/S Guide to GMP for Medicinal Products (PE 009-17) Annex 1 is expected to be adopted by the Therapeutic Goods Administration (TGA) in 2025 and Contamination Control Strategy (CCS) has emerged as a key new requirement. While CCS under Annex 1 is central for sterile drug manufacturers, it is also applicable for...
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a non-profit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance...
PCI Pharma Services (PCI) is an international contract development manufacturing organisation (CDMO) in the pharmaceutical industry, with a network of operations and facilities worldwide. PCI is equipped to support clients looking for assistance with drug product development to clinical trials and beyond. In Melbourne, PCI offers support with the...
Copyright © SeerPharma
